Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting tyrosine kinases involved in cancer cell signaling. Shows potential in developing treatments for oncological diseases due to its ability to modulate cellular pathways related to proliferation and apoptosis. Also employed in the design of small-molecule therapeutics with improved selectivity and binding affinity. Its structure supports derivatization for optimizing pharmacokinetic properties in drug development programs.